Should I Buy MIR? MIR 2026 Analysis

Should You Buy Mirion Technologies Inc (MIR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

24.840

1 Day change

-1.78%

52 Week Range

30.280

Analysis Updated At

2026/01/30

MIR is not a good buy right now for an impatient investor. The setup is tactically weak (bearish MACD, price sitting just above support) while insider selling has surged and options flow shows heavy put volume. Even though Street price targets cluster around ~$29–$33 and the nuclear theme remains a positive backdrop, the near-term risk/reward does not favor an immediate entry at $25.43 without a clearer reversal signal.

Technical Analysis

Trend/structure: Price ($25.43) is below the pivot (26.123) and sitting just above first support (S1=25.10). That means downside risk is immediate if 25.10 breaks, with the next support at S2=24.467. Upside levels to reclaim are 26.123 first, then R1=27.147. Momentum: MACD histogram is negative (-0.12) and expanding lower, signaling bearish momentum is strengthening rather than stabilizing. RSI(6)=36.6 is not yet deeply oversold, so there is room for further weakness before a typical oversold bounce signal appears. Moving averages: Converging MAs suggests consolidation, but with MACD weakening and price below pivot, the consolidation bias is currently tilted down. Quant-style outlook from provided pattern study: expected -3.7% over the next month (with only small expected gains over the next week), which aligns with the current bearish momentum. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): no signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Sentiment read: Open interest put/call at 0.45 is generally constructive (more calls outstanding than puts), but the option *volume* put/call at 8.23 is strongly bearish on the day, indicating traders are actively buying/trading puts versus calls. Volatility: IV percentile 86.8 (with 30D IV ~62.7 vs HV ~74.7) implies options are priced with elevated implied volatility versus most of the past year—consistent with uncertainty/hedging demand ahead of catalysts. Today’s volume is ~81.6% of the 30D average, so the bearish put skew is meaningful even without an extreme volume spike.

Technical Summary

Sell

Buy

Positive Catalysts

Earnings catalyst: QDEC 2025 earnings scheduled for 2026-02-10 (after hours) with EPS estimate ~0.15—an upside surprise could quickly re-rate the stock.
Secular tailwinds: multiple analysts cite nuclear buildout/AI-data-center power demand and Mirion’s “picks-and-shovels” positioning in radiation detection/monitoring.
Analyst support: recent coverage includes Outperform/Buy ratings with targets around $29–$33, implying upside vs $25.43 if execution is solid.
Margin trajectory narrative: Evercore highlighted a path toward ~30% adjusted EBITDA margins (if realized, supports a higher multiple).

Neutral/Negative Catalysts

Insider selling: insiders are selling, with selling amount up ~1999.77% over the last month—this is a near-term confidence overhang.
Weak technical momentum: bearish MACD expansion and price below pivot; failure to hold 25.10 could trigger a sharper move toward ~24.
Options flow risk-off: very high put/call volume ratio (8.
suggests near-term hedging/speculation skewed bearish.
Valuation/expectations risk: Morgan Stanley initiated at Equal Weight and explicitly noted “premium valuation” and that positive revisions may be hard—i.e., expectations already elevated.
Hedge funds neutral: no strong institutional accumulation signal over the last quarter based on provided trend summary.

Financial Performance

Latest quarter provided: 2025/Q3. Revenue grew to $223.1M (+7.88% YoY), and gross margin improved to 46.84% (+4.27% YoY), showing solid top-line growth and better gross profitability. However, net income fell to $2.9M (-121.32% YoY) and EPS declined to $0.01 (-114.29% YoY), indicating earnings pressure (mix, operating costs, integration/one-time items, or other below-the-line impacts). Overall: growth is positive, but profitability/earnings consistency is the key issue the market will likely focus on into the 2026-02-10 earnings event.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Ratings are mostly constructive (Buy/Outperform) with targets generally clustered at ~$29 (Northland Top Pick for 2026 at $29; Evercore Outperform at $29) and Citi maintaining Buy while trimming target to $33 from $35. The newest note (2026-01-23) is Morgan Stanley initiating at Equal Weight with a $29 target, emphasizing that nuclear optimism may already be priced in due to a premium valuation. Wall Street pros: strong nuclear/AI power demand tailwind, diversified “picks-and-shovels” exposure, margin expansion story, broad reactor fleet penetration. Wall Street cons: valuation/expectations appear high, harder path to positive estimate revisions, and near-term execution/earnings quality must improve. Influential/politician activity: No recent congress trading data available in the last 90 days.

7 Analyst Rating

Wall Street analysts forecast MIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MIR is 30.67 USD with a low forecast of 29 USD and a high forecast of 34 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

0 Hold

0 Sell

Strong Buy

Current: 25.290

Low

Averages

30.67

High

Current: 25.290

Low

Averages

30.67

High

Morgan Stanley

Equal Weight

initiated

$29

AI Analysis

2026-01-23

Reason

Morgan Stanley

Price Target

$29

AI Analysis

2026-01-23

initiated

Equal Weight

Reason

Morgan Stanley initiated coverage of Mirion with an Equal Weight rating and $29 price target. While Mirion will benefit from additional global nuclear power generation capacity driven by data centers and utilization of new technologies, the Street is "well-calibrated for this optimism" and "positive revisions will be hard to come by" when also factoring the stock's "premium valuation," the analyst tells investors.

Northland

Jeff Grampp

Outperform

maintain

$29

2025-12-31

Reason

Northland

Jeff Grampp

Price Target

$29

2025-12-31

maintain

Outperform

Reason

Northland analyst Jeff Grampp names Mirion as a Top Pick for 2026 and the analyst's "favorite way to play the nuclear power theme." The technology-agnostic, picks-and-shovels provider of critical radiation detection and monitoring products and services is seeing strong organic growth and recent acquisitions have expanded its exposure to the nuclear power end-market, with potential growth upside through accelerated nuclear power industry investments, says the analyst, who has an Outperform rating and $29 price target on Mirion shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MIR

Unlock Now

MIR Should I Buy

MIR Should I Buy

Should You Buy Mirion Technologies Inc (MIR) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch